STAT Plus: 4 questions for neurology startups as venture investors pour millions into the field
As pharmaceutical companies stepped back from developing new drugs for neurological conditions, venture capitalists took…
Category: startup
As pharmaceutical companies stepped back from developing new drugs for neurological conditions, venture capitalists took…